重新思考监管层次:医疗保险现实世界的证据表明,CAMP结果独立于FDA监管分类
William H Tettelbach1,2,3,4, David G Armstrong5, Travis Tucker6
1Chief Medical Officer, RestorixHealth, Metairie, LA, US.
Journal of wound care
|January 13, 2026
概括
细胞,非细胞和矩阵类产品 (CAMPs) 与标准护理相比,改善了糖尿病和静脉腿的治疗结果. 监管分类没有预测现实世界的有效性,这表明支付应该关注患者的结果,而不是FDA的类别.
科学领域:
- 伤口愈合 伤口愈合
- 生物材料是一种生物材料.
- 医疗服务研究 医疗服务研究
背景情况:
- 细胞,非细胞和矩阵类产品 (CAMP) 用于下肢糖尿病 (LEDU) 和静脉腿 (VLU).
- 有限的证据显示,美国食品和药物管理局 (FDA) 的监管类别 (第361条,第510条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条,第1010条) 的临床结果在美国食品和药物管理局 (FDA) 的监管类别 (第361条,第510条,第1010条,第1010条,第1010条) 中存在差异.
- 监管类别根据来源,操纵和目的区分CAMP,没有证明比较有效性.
研究的目的:
- 评估监管分类是否预测CAMPs的实际临床有效性.
- 在Medicare受益者中,将CAMP治疗的发作与单独的标准护理 (SoC) 进行比较.
- 评估CAMPs的不同FDA监管途径的结果.
主要方法:
- 来自CMS数据的265万LEDU和745411VLU情节 (2016-2024) 的回顾性队列研究.
- 根据FDA监管类别分层的CAMP事件;四向1:1匹配的平衡队列.
- 结果包括治疗时间,截肢,感染,死亡率和医院利用率.
主要成果:
- 在CAMP调节途径之间观察到最小的结果差异.
- 所有CAMP类别的表现明显优于单独的SoC,减少死亡率,重大截肢和医院使用.
- 益处在伤口大小和病因方面是一致的,VLU发作长度和轻微截肢是少数例外.
结论:
- 监管途径并不能有意义地预测CAMP在Medicare受益人的实际有效性.
- 与单独的SoC相比,CAMP治疗加SoC改善了结果,并减少了并发症/住院治疗.
- 支付政策应优先考虑以患者为中心的结果,而不是CAMP的FDA监管类别.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Bioequivalence studies: Biowaivers
218
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
218
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinically Relevant Drug Product Specifications: Methods of Establishment
199
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
199
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K


